Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
Genes & Development|December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant gliomaKrishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
Nature Cancer|April 18, 2024
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumorsSanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee, et al.
Pediatric Blood & Cancer|November 20, 2013
Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumorsKeita Terashima, Alexander Yu, Wing-Yuk T Chow, et al.
Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.
Neuro-Oncology|March 22, 2008
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomasKathleen R Lamborn, W K Alfred Yung, Susan M Chang, et al.
Cancer|March 11, 2020
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcomaEudocia Q Lee, Peixin Zhang, Patrick Y Wen, et al.
Acta Neuropathologica|October 7, 2020
Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Journal of Neuro-Oncology|July 6, 2019
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastomaAndrew B Lassman, Kenneth D Aldape, Peter J Ansell, et al.
Nature Communications|May 10, 2023
Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilitiesSuganth Suppiah, Sheila Mansouri, Yasin Mamatjan, et al.
Pageof 20